guest ::
| Home > Publications database > Intratumoral oncolytic adenoviral treatment modulates the glioma microenvironment and facilitates systemic tumor-antigen-specific T cell therapy > print |
| Home > Publications database > Intratumoral oncolytic adenoviral treatment modulates the glioma microenvironment and facilitates systemic tumor-antigen-specific T cell therapy > print |
| 001 | 127332 | ||
| 005 | 20240228140919.0 | ||
| 024 | 7 | _ | |a 10.1080/2162402X.2015.1022302 |2 doi |
| 024 | 7 | _ | |a WOS:000360239300016 |2 WOS |
| 024 | 7 | _ | |a 2162-4011 |2 ISSN |
| 024 | 7 | _ | |a 2162-402X |2 ISSN |
| 024 | 7 | _ | |a altmetric:4557276 |2 altmetric |
| 024 | 7 | _ | |a pmid:26405578 |2 pmid |
| 037 | _ | _ | |a DKFZ-2017-03357 |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Qiao, Jian |b 0 |
| 245 | _ | _ | |a Intratumoral oncolytic adenoviral treatment modulates the glioma microenvironment and facilitates systemic tumor-antigen-specific T cell therapy |
| 260 | _ | _ | |a Austin, Tex. |c 2015 |b Landes Bioscience |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1525419068_19708 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 536 | _ | _ | |a 316 - Infections and cancer (POF3-316) |0 G:(DE-HGF)POF3-316 |c POF3-316 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to Web of Science, Web of Science, , CrossRef |
| 700 | 1 | _ | |a Dey, Mahua |b 1 |
| 700 | 1 | _ | |a Chang, Alan L |b 2 |
| 700 | 1 | _ | |a Kim, Julius W |b 3 |
| 700 | 1 | _ | |a Miska, Jason |b 4 |
| 700 | 1 | _ | |a Ling, Alex |b 5 |
| 700 | 1 | _ | |a M Nettlebeck, Dirk |0 P:(DE-HGF)0 |b 6 |
| 700 | 1 | _ | |a Han, Yu |b 7 |
| 700 | 1 | _ | |a Zhang, Lingjiao |b 8 |
| 700 | 1 | _ | |a Lesniak, Maciej S |b 9 |
| 773 | _ | _ | |a 10.1080/2162402X.2015.1022302 |g Vol. 4, no. 8, p. e1022302 - |0 PERI:(DE-600)2645309-5 |n 8 |p e1022302 - |t OncoImmunology |v 4 |y 2015 |x 2162-402X |
| 909 | C | O | |o oai:inrepo02.dkfz.de:127332 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-HGF)0 |
| 913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-316 |2 G:(DE-HGF)POF3-300 |v Infections and cancer |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
| 914 | 1 | _ | |y 2015 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b ONCOIMMUNOLOGY : 2015 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b ONCOIMMUNOLOGY : 2015 |
| 920 | 1 | _ | |0 I:(DE-He78)F110-20160331 |k F110 |l Onkolytische Adenoviren |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)F110-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|